| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4934913 | Schizophrenia Research | 2017 | 8 Pages |
Abstract
Polypharmacy is as efficacious and safe as, but cheaper than, monotherapy in the acute treatment of schizophrenia. Whether our findings can be generalized to other combinations of an appropriate ratio of one FGA to another SGA dosage, which can achieve favorable clinical responses and side effect profiles, needs further investigation.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ching-Hua Lin, Fu-Chiang Wang, Shih-Chi Lin, Yu-Hui Huang, Cheng-Chung Chen,